Navigation

Prostate cancer - cabazitaxel [ID400]

Cabazitaxel for the second line treatment of hormone refractory, metastatic prostate cancer

Status: History
Expected date of issue: February 2012
Referral date: September 2010
Process: STA
Notes:

Scoped within Batch 13

Topic area:
  • Cancer
  • Urogenital
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Anwar Jilani
Communications manager: Alice Law
Project manager: Jeremy Powell
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 8 June 2011
1st appraisal committee meeting: 06 September 2011
2nd appraisal committee meeting 01 November 2011
Top


 

Consultees and commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Sanofi-aventis (cabazitaxel)

Patient/carer groups

  • Equalities National Council
  • Macmillan Cancer Support
  • Prostate Cancer Charity
  • Prostate Cancer Support Federation

Professional groups

  • British Uro-Oncology Group
  • Royal College of Nursing
  • Royal College of Physicians

Others

  • Department of Health
  • NHS Warwickshire
  • Welsh Government

General

  • British National Formulary
  • Commissioning Support Appraisals Service
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare Products Regulatory Agency
  • NHS Healthcare improvement Scotland

Possible comparator manufacturers

Relevant research groups

  • MRC Clinical Trials Unit
  • Prostate Action

Evidence Review Group

  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • National Collaborating Centre for Cancer

Associated Public Health Groups

  • None

Top


 

Project history

Date

 

Update

 

22 December 2010

 

Please note that following on from information received from the manufacturer, this appraisal has been rescheduled, in order to ensure the inclusion of key research evidence that would not have been available at the time of the original submission deadline.

Therefore, we now anticipate that the appraisal will begin during late March 2011 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately early June 2011.

Top


 

Key documents

This page was last updated: 11 July 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.